Fast Company magazine has named Medicines Development for Global Health Founder Mark Sullivan to its 2019 list of ‘100 Most Creative People in Business’, for his vision in establishing MDGH to address health inequity, and the novel funding approach that was applied. Read the full article here.
Mark himself acknowledges that this award is not just his. “It takes a small city to bring a new drug to approval, and there’s no way we could have done this without the support and especially the creativity of our many partners. In particular, the vision for moxidectin in River Blindness started with the World Health Organization’s Special Programme for Research and Training in Tropical Diseases (WHO-TDR), who have resolutely sought this goal for many years and have been enthusiastic partners to us.”
Fast Company is a highly-regarded magazine based in New York. It is dedicated to the intersection of business, innovation, and design, and engages with the world’s most influential leaders and companies on the future of business. It has received numerous prestigious editorial and design accolades, with a reported circulation of 700,000 and over 11 million average monthly unique online visitors in 2018.